No Data
No Data
A major favorable raid, and the 1.6 trillion innovative drug sector is booming!
The advantage suddenly “smashed” into the pharmaceutical sector!
Chia Tai Enterprise International (03839) announced annual results, with profit attributable to shareholders of US$2.553 million
Chia Tai Enterprise International (03839) announced results for the year ended December 31, 2023, with revenue of 174 million...
Chia Tai Enterprise International (03839.HK)'s annual revenue rose 9.3% to US$174 million
On February 23, GLONGHUI | Chia Tai Enterprise International (03839.HK) announced that for the year ended December 31, 2023, the company's revenue increased 9.3% to US$174 million. However, overall gross margin fell from 24.6% in 2022 to 19.4% in 2023, mainly due to falling prices of chlormycin products and an increase in trading business with lower profit margins. Profit attributable to shareholders of the company was US$2.6 million (2022: loss of US$6.7 million). The shift from loss to profit is mainly due to improvements in industrial business performance, which should account for Yichumingtong's profit and loss losses from 2022
正大企業國際:截至二零二三年十二月三十一日止年度之全年業績公告
Chia Tai Enterprise International (03839.HK): Zhang Manqi was appointed as an independent non-executive director
Gelonghui, Feb. 23 | Chia Tai Enterprise International (03839.HK) announced that Zhang Manqi has been appointed as an independent non-executive director and a member of the Remuneration Committee and Nomination Committee.
A quick overview of the Hong Kong market | The Hang Seng Index rose nearly 2%, and the Science Index rose nearly 3%; insurance, real estate and other sectors were strong throughout the day
Technet stocks were strong. Meituan rose nearly 5%, Bilibili and Kuaishou rose more than 3%, Xiaomi and Jingdong rose more than 2%, Baidu, Ali, and Tencent rose more than 1%, and NetEase followed; insurance stocks were strong throughout the day. China Ping An rose more than 6%, China Life Insurance rose nearly 5%, and AIA Insurance rose more than 2%.
No Data